Digicann Ventures to Resume Trading on the Canadian Securities Exchange
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2025) - Digicann Ventures Inc. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, is pleased to announce that its common shares will resume trading on the Canadian Securities Exchange (the "CSE") on November 11, 2025, under the ticker symbol "DCNN.X". Trading of the securities was halted on September 30, 2024, in connection with the ann
Banking / Financial Services, Cannabis
2025-11-10 9:00 PM EST | Digicann Ventures Inc.
Delivra Health Brands Reports Financial Results for First Quarter of Fiscal 2026 Highlighting Continued Growth of Dream Water (R) and LivRelief(TM)
Growth of Dream Water® US and Canada by 8% compared to same quarter last year Growth of Dream Water® E-commerce by 74% compared to same quarter last year Growth of LivRelief™ by 9% compared to same quarter last year Growth of LivRelief™ E-commerce by 16% compared to same quarter last year Vancouver, British Co
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2025-11-10 7:25 AM EST | Delivra Health Brands Inc.
C21 Investments to Report Second Quarter Financial Results on November 11, 2025
Vancouver, British Columbia--(Newsfile Corp. - November 7, 2025) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced it will release its financial results for the second quarter ended September 30, 2025, on Tuesday, November 11, 2025, before market open. For further inquiries, please contact:
Cannabis, Cannabis Cultivator, Cannabis Extractor, Cannabis Manufacturer
2025-11-07 7:00 AM EST | C21 Investments Inc.
Nextleaf Announces Launch of New Recreational Cannabis Brand
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to announce the national launch of its new recreational brand, Yard. Yard is designed for adult-use consumers seeking bold recreational cannabis experiences through high-potency extracts, premium hardware, and flavour-forward formul
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2025-11-06 9:29 AM EST | Nextleaf Solutions Ltd.
Elixxer Ltd. Provides Update and Corrective Statements on Proposed Debt Settlement and Upcoming Shareholder Meeting
Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Elixxer Ltd. (TSXV: ELXR.H) ("Elixxer" or the "Company") announces that it has called its annual and special shareholder meeting (the "Meeting") of shareholders of the Company, to be held on Tuesday, December 30, 2025. The management information circular and related materials will be mailed to shareholders of the Company and filed on the Company's profile on SEDAR+ on or about November 25, 2025. At the Meeting
2025-11-06 8:55 AM EST | Elixxer Ltd.
Cardiol Therapeutics' Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases
The ESC M&PD meeting brings together the world's experts working to improve the treatment of myocarditis and pericarditis. Presentation to provide comprehensive findings from the ARCHER trial following the reporting of topline results demonstrating a notable improvement in extracellular volume and a significant reduction in left ventricular mass. The Company will host a webcast conference call on Decembe
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-11-05 7:45 AM EST | Cardiol Therapeutics Inc.
PharmaDrug Announces Debt Restructuring
Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has agreed to issue $445,686 principal amount of secured convertible debentures to two current holders of the Company's secured convertible debentures that were past their maturity date. Each Debe
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-10-31 8:58 AM EDT | PharmaDrug Inc.
Herbal Dispatch Brings on Industry Veteran as Strategic Advisor
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2025) - Herbal Dispatch Inc. (CSE: HERB) (OTC Pink: LUFFF) (FSE: HA9) ("Herbal Dispatch" or the "Company"), a leader in cannabis distribution, is pleased to welcome Jay Wilgar, a 20-year veteran in startup management and business growth, to its team as a Strategic Advisor to the management team. Mr. Wilgar is the former CEO and Chairman of Newstrike Brands Ltd.—one of Canada's first licensed cannabis p
Pharmaceuticals, Cannabis, Cannabis Dispensary
2025-10-30 9:00 AM EDT | Herbal Dispatch Inc.
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc
Toronto, Ontario--(Newsfile Corp. - October 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has executed a definitive securities exchange agreement (the "Definitive Agreement") with Canurta Limited Partnership ("Canurta") and each of the limited partners of Canurta, the parent en
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-10-30 9:00 AM EDT | PharmaDrug Inc.
Digicann Ventures Agrees to Mutual Termination of Business Combination Agreement with 3Win Corp. and D-3 Merger Sub, Inc.
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2025) - Digicann Ventures Inc. (CSE: DCNN) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, announces that on October 22, 2025 it entered into a Termination, Settlement and Release Agreement (the "Settlement Agreement") with 3Win Corp. ("3Win") and D-3 Merger Sub, Inc. to mutually terminate the Business Combination Agreement dated September 27
Banking / Financial Services, Cannabis
2025-10-29 4:30 PM EDT | Digicann Ventures Inc.
Flora Growth Corp. Announces Second Purchase of 0G, the Fuel of the 0G Decentralized AI Network
Fort Lauderdale, Florida--(Newsfile Corp. - October 21, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (the "Company"), which is set to rebrand as ZeroStack, and is the first public company to offer exposure to Decentralized AI through the accumulation of $0G, the native cryptocurrency of the distributed AI infrastructure project 0G ("0G"), today announced the purchase of 880,025 $0G at an average price of $2.27. The purchase represents the Company's second acquisition of $0G since its most recent
Cannabis, Cannabis Cultivator, Cannabis Manufacturer, Crypto
2025-10-21 8:00 AM EDT | Flora Growth Corp.
Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardiology conference in November 2025. Next-generation therapy CR
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-10-21 7:27 AM EDT | Cardiol Therapeutics Inc.
Akanda Corp. Increasing Its Cannabis Investment
Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), through its cannabis operating subsidiary, has furthered its cannabis investment by extending its option on its British Columbia asset for two additional years. The Company has been working on obtaining its full cultivation license for a variety of potential products containing THC, but currently it is operating under its hemp cultivation license. A further extension of the license
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-10-20 8:00 AM EDT | Akanda Corp
Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx™ in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardiology conference in November 2025. Next-generation therapy CR
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2025-10-17 4:34 PM EDT | Cardiol Therapeutics Inc.
Akanda To Accelerate Recurring Revenue with Expansion Of Up To 20 New Cellular Towers
Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today a major network expansion initiative with the construction of new cellular towers within the proximity of its existing tower network. The Company plans to construct and/or acquire up to 20 new or existing towers/sites by the end of
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2025-10-16 4:15 PM EDT | Akanda Corp
Flora Growth Corp. Appoints BitGo as Custodian for $0G Treasury
Fort Lauderdale, Florida--(Newsfile Corp. - October 16, 2025) - Flora Growth Corp. (NASDAQ: FLGC), which is set to rebrand as ZeroStack (the "Company"), the first and largest decentralized AI treasury company, has appointed BitGo Trust Company, Inc. ("BitGo") to provide institutional-grade custody for the Company's $0G treasury. BitGo, the digital asset infrastructure company, has enabled its clients to securely navigate the digital asset space since 2013 by delivering custody, wallets,
Cannabis, Cannabis Cultivator, Cannabis Manufacturer, Crypto
2025-10-16 8:00 AM EDT | Flora Growth Corp.
Adastra Holdings Announces Completion of Sale of Subsidiaries
Langley, British Columbia--(Newsfile Corp. - October 15, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has completed the sale of all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd. ("Adastra Labs"), 1178562 B.C. Ltd. ("1178562"), and Adastra Brands Inc. ("Adastra Brands"), to 1538634 B.C. Ltd. (the "Purchaser
2025-10-15 6:57 PM EDT | Adastra Holdings Ltd.
City View Announces ArkenYield Partnership with Unique Digital Assets Ltd. to Manage up to $500M for Institutional Depositors
Toronto, Ontario--(Newsfile Corp. - October 15, 2025) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (FSE: CVY0) (the "Company" or "City View") announces that, investee company ArkenYield Ltd. ("ArkenYield"), has recently entered into a strategic partnership with Unique Digital Assets Ltd. ("UDA"), a licensed and regulated financial service provider specializing in digital asset custody OTC trading, payment and yield solutions. Pursuant to the partnership, ArkenYie
Food / Beverages, Cannabis, Cannabis Extractor, Cannabis Manufacturer
2025-10-15 6:00 AM EDT | City View Green Holdings Inc.
Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company's Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs
Toronto, Ontario--(Newsfile Corp. - October 14, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-10-14 8:34 AM EDT | Red Light Holland Corp.
CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery
Houston, Texas--(Newsfile Corp. - October 13, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) today announced the addition of a patent-pending nanoemulsion formulation to its growing portfolio, developed to support female fertility and reproductive function in women of advanced maternal age (35+). CBIH believes this innovation should expand evidence-based options for patients and partners. As age is a key determinant of reproductive outcomes—and first births
Biotechnology, Pharmaceuticals, Cannabis, Health
2025-10-13 7:00 AM EDT | Cannabis Bioscience International Holdings